Lab site: Serious Mental Illness Research Group
Dr. Spaulding received his Ph.D. from the University of Arizona in 1976 and completed a postdoctoral Fellowship in Mental Health Research and Teaching at the University of Rochester, 1976-1979. He joined the UN-L faculty in 1979. His research interests address various aspects of schizophrenia and other severe disorders, including clinical and experimental psychopathology, the effectiveness of treatment and rehabilitation, and service systems and social policy. Recent projects in his research group have included neuropsychological impairment in schizophrenia, the nature of schizotypy, cognitive and neuropsychological predictors of success in treatment and rehabilitation, neuroendocrine aspects of schizophrenia, assessment of stress and coping in rehabilitation, social cognition in psychosis, the effectiveness of cognitive treatment, mental health system reform, and the impact of the US Supreme Court’s Olmstead ruling. His graduate students include individuals in the regular clinical Ph.D. track and clinical students in the UNL Law-Psychology program. His law-psychology students are generally interested in law and social policy related to severe mental illness, and therapeutic jurisprudence (using the law for therapeutic purposes). Dr. Spaulding also has general interests in psychopharmacology and the integration of psychopharmacological and psychological treatment. He teaches graduate courses on psychopathology, treatment, professional ethics, and the history and philosophy of psychology, and supervises clinical practicum training. His recent book, The Schizophrenia Spectrum (Hogrefe, 2017), with co-authors Steven Silverstein and Anthony Menditto, is a comprehensive integration of theory, research and practice principles. Dr. Spaulding is an editor of American Journal of Orthopsychiatry, the journal of the Global Alliance for Behavioral Health and Social Justice. He maintains an active clinical and consulting practice.
- Spaulding, W., Johnson, R., Nolting, J. & Collins, A. (in press) Treatment resistant schizophrenia. In D. Castle, D. Copolov, T. Wykes & K. Mueser (eds), Pharmacological and psychosocial treatment of schizophrenia (4th ed.), London: Taylor & Francis.
- Spaulding, W. & Nolting, J. (2006) Psychotherapy for schizophrenia in the year 2030: Prognosis and prognostication. Schizophrenia Bulletin 32S1, s94-S105.
- Silverstein, S., Spaulding, W. & Menditto, A. (2006) Schizophrenia. New York: Hogrefe.
- Spaulding, W., Sullivan, M. and Poland, J. (2003) Treatment and rehabilitation for severe mental illness, New York: Guilford.
- Spaulding, W. & Poland, J. (2001) Cognitive rehabilitation for schizophrenia: Enhancing social cognition by strengthening neurocognitive functioning. In P. Corrigan & D. Penn (Eds.) Social cognition in clinical psychology. Washington DC: American Psychological Association. pp 217-248
- Spaulding, W., Johnson, D. & Coursey, R. (2001) Treatment and rehabilitation of schizophrenia. In M. Sammons & N. Schmidt (eds) Combined Treatments for Mental Disorders: A guide to psychological and pharmacological interventions. Washington, D.C.: American Psychological Association.
- Spaulding, W., Poland, J., Elbogen, E. & Ritchie, J. (2000) Therapeutic juripsrudence in psychiatric rehabilitation. Thomas M. Cooley Law Review 17(1), 135-170.
- Spaulding, W. (editor) (1999) The role of the state hospital in the twenty first century. New Directions in Mental Health Services #84; San Francisco: Jossey Bass.
- Spaulding, W., Fleming, S. Reed, D., Sullivan, M., Storzbach, D. & Lam, M (1999) Cognitive functioning in schizophrenia: Implications for psychiatric rehabilitation, Schizophrenia Bulletin 25: 275-289.
- Spaulding, W., Reed, D., Sullivan, M. Richardson, C. & Weiler, M. (1999) Effects of cognitive treatment in psychiatric rehabilitation, Schizophrenia Bulletin 25: 657-676.